Biosion, Inc. ("Biosion"), a global clinical stage biotechnology company, today announced the appointment of Joel Edwards as chief business officer. In this position, he is responsible...
Synthego, the genome engineering company, announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also...
PolarityTE, Inc. , a biotechnology company developing regenerative tissue products and biomaterials, announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice...
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced that...
Enveric Biosciences , a cutting-edge neuroscience company developing next-generation, psychedelic-inspired mental health medicines, is working with the University of Calgary's Hotchkiss Brain Institute ("HBI"),...
